From Exclusion to Inclusion: Analysing Follow-up Discontinuity in Breast Cancer

Launched by BASAVATARAKAM INDO AMERICAN CANCER HOSPITAL & RESEARCH INSTITUTE · Apr 13, 2025

Keywords

ClinConnect Summary

This clinical trial, titled "From Exclusion to Inclusion," is focused on understanding why some women with breast cancer don’t continue their follow-up care after treatment. Specifically, researchers want to find out how many patients are lost to follow-up after five years, what factors contribute to this, and what barriers patients themselves report that might prevent them from returning for care. By looking at these issues, the study aims to see if proactive outreach programs can help improve follow-up rates for women who have been categorized as "lost-to-follow-up."

To be eligible for this study, participants must be women who were newly diagnosed with non-metastatic breast cancer between 2017 and 2018 and are willing to re-engage in their healthcare. The trial will include all ages from 65 to 74 and is set to take place at a public cancer care center. While the study is not yet recruiting participants, those who choose to take part can expect to share their experiences and insights about their follow-up care. This valuable information may help improve support for future patients in similar situations.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • 1. Patients newly diagnosed with non-metastatic breast cancer between 2017-2018
• • 2. Patients categorized as "lost-to-follow-up", as defined above
• • 3. Patients willing to participate upon re-engagement
• Exclusion Criteria:
• • 1. Patients with incomplete medical records
• • 2. Patients who have taken part of the treatment at another hospital/centre
• • 3. Patients who have relocated permanently out of the study region
• Withdrawal Criteria:
• • 1. Patient withdraws consent